Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) shares rose in pre-market trading after the company reported third-quarter results before the open. Adjusted earnings per share of $1.32 were above estimates that varied by data provider between $0.80 and $1.12. Revenue of $356.0 million was about 8% above …
Insmed Incorporated (NASDAQ:INSM) shares surged in pre-market trading after third-quarter results showed revenue of $524.4 million, about 5% above the market estimate of roughly $500 million. The adjusted loss of $0.46 per share was wider than the $0.34 loss the market expected, but attention …
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) shares fell sharply in pre-market trading after the company published updated Phase 2 results for lifileucel in previously treated non-squamous metastatic non-small cell lung cancer. The shares had risen 11% to 12% in late Wednesday trading on the announcement of …
Novocure Ltd (NASDAQ:NVCR) shares moved higher in pre-market trading after the company posted a third-quarter loss of $0.09 per share, well inside the $0.21 to $0.24 loss the market had expected. Revenue of $193.4 million was about 6% above the roughly $182 million estimate …
Teladoc Health, Inc. (NYSE:TDOC) shares climbed in pre-market trading after a third-quarter report that topped expectations on revenue and showed a narrower loss. Revenue of $605.1 million fell about 3% from a year earlier but landed near the high end of company guidance. The …
Viking Therapeutics, Inc. (NASDAQ:VKTX) shares edged lower in pre-market trading after third-quarter results showed a net loss of $183.2 million, or $1.55 per share, wider than the loss of $1.00 to $1.06 the market expected. Research and development expense was $166.8 million, up from …
● Quarterly revenue rose 26.2% year over year, beating modest prior expectations.
● The decline did not stem from weak underlying demand.
● No confirmed company-specific catalyst was identified behind the drop.
● No confirmed company-specific catalyst was identified behind the move.